CompletedNot Applicable

Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"

Japan1,237 participantsStarted 2016-03-01

Plain-language summary

The purpose of this survey is to evaluate the safety and effectiveness of long-term administration of vonoprazan tablets when used as maintenance therapy for reflux esophagitis in routine clinical settings.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Participants who require maintenance therapy for relapsed/recurrent reflux esophagitis Exclusion Criteria: * Participants meeting the criteria of grade A to D according to the Los Angeles classification (Hoshihara's modification), by means of endoscopy at the initiation of maintenance therapy with vonoprazan tablets * Participants with a previous history of hypersensitivity to ingredients in vonoprazan tablets * Participants taking atazanavir sulfate or rilpivirine hydrochloride

What they're measuring

Percentage of Participants Who Had One or More Adverse Drug Reactions

Timeframe: Up to 12 months

Trial details

NCT IDNCT03214081

SponsorTakeda

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2018-08-31

Results submitted2019-08-29

View on ClinicalTrials.gov More Reflux Esophagitis trials